awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26851183-687CF243-3DE4-496A-AF5F-2B5BC57F2C1E
Q26851183-687CF243-3DE4-496A-AF5F-2B5BC57F2C1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851183-687CF243-3DE4-496A-AF5F-2B5BC57F2C1E
Anti-angiogenesis in prostate cancer: knocked down but not out
P2860
Q26851183-687CF243-3DE4-496A-AF5F-2B5BC57F2C1E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26851183-687CF243-3DE4-496A-AF5F-2B5BC57F2C1E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4988807834be913478bcf0774f44cb059c38bde8
P2860
Continuation of bevacizumab after first progression in metastatic colorectal cancer (ML18147): a randomised phase 3 trial.